Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome

Oliver Rivero-Arias, Melissa Ouellet, Alastair Gray, Jane Wolstenholme, Peter M. Rothwell and Ramon Luengo-Fernandez
Additional contact information
Oliver Rivero-Arias: Health Economics Research Centre, Department of Public Health, University of Oxford, UK, oliver.rivero@dphpc.ox.ac.uk
Melissa Ouellet: Health Economics Research Centre, Department of Public Health, University of Oxford, UK
Jane Wolstenholme: Health Economics Research Centre, Department of Public Health, University of Oxford, UK
Peter M. Rothwell: Stroke Prevention Research Unit, University Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK
Ramon Luengo-Fernandez: Health Economics Research Centre, Department of Public Health, University of Oxford, UK

Medical Decision Making, 2010, vol. 30, issue 3, 341-354

Abstract: Background. Mapping disease-specific instruments into generic health outcomes or utility values is an expanding field of interest in health economics. This article constructs an algorithm to translate the modified Rankin scale (mRS) into EQ-5D utility values. Methods. mRS and EQ-5D information was derived from stroke or transient ischemic attack (TIA) patients identified as part of the Oxford Vascular study (OXVASC). Ordinary least squares (OLS) regression was used to predict UK EQ-5D tariffs from mRS scores. An alternative method, using multinomial logistic regression with a Monte Carlo simulation approach (MLogit) to predict responses to each EQ-5D question, was also explored. The performance of the models was compared according to the magnitude of their predicted-to-actual mean EQ-5D tariff difference, their mean absolute and mean squared errors (MAE and MSE), and associated 95% confidence intervals (CIs). Out-of-sample validation was carried out in a subset of coronary disease and peripheral vascular disease (PVD) patients also identified as part of OXVASC but not used in the original estimation. Results. The OLS and MLogit yielded similar MAE and MSE in the internal and external validation data sets. Both approaches also underestimated the uncertainty around the actual mean EQ-5D tariff producing tighter 95% CIs in both data sets. Conclusions. The choice of algorithm will be dependent on the study aim. Individuals outside the United Kingdom may find it more useful to use the multinomial results, which can be used with different country-specific tariff valuations. However, these algorithms should not replace prospective collection of utility data.

Keywords: stroke; modified Rankin scale; EQ-5D; mapping. (search for similar items in EconPapers)
Date: 2010
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X09349961 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:30:y:2010:i:3:p:341-354

DOI: 10.1177/0272989X09349961

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().